Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Coya Therapeutics (COYA) Return on Sales (2023 - 2025)

Coya Therapeutics' Return on Sales history spans 3 years, with the latest figure at 0.68% for Q3 2025.

  • For Q3 2025, Return on Sales rose 42.0% year-over-year to 0.68%; the TTM value through Sep 2025 reached 4.99%, down 389.0%, while the annual FY2024 figure was 4.19%, 286.0% down from the prior year.
  • Return on Sales for Q3 2025 was 0.68% at Coya Therapeutics, up from 37.25% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.3% in Q4 2023 and bottomed at 2090.32% in Q4 2024.
  • The 3-year median for Return on Sales is 14.72% (2025), against an average of 274.76%.
  • The largest annual shift saw Return on Sales tumbled -209062bps in 2024 before it skyrocketed 1150bps in 2025.
  • A 3-year view of Return on Sales shows it stood at 0.3% in 2023, then crashed by -691308bps to 2090.32% in 2024, then surged by 100bps to 0.68% in 2025.
  • Per Business Quant, the three most recent readings for COYA's Return on Sales are 0.68% (Q3 2025), 37.25% (Q2 2025), and 28.33% (Q1 2025).